GE HealthCare Technologies (NASDAQ:GEHC) Updates FY 2025 Earnings Guidance

GE HealthCare Technologies (NASDAQ:GEHC) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 3.900-4.100 for the period, compared to the consensus earnings per share estimate of 4.690. The company issued revenue guidance of -.

GE HealthCare Technologies Trading Up 0.0 %

NASDAQ:GEHC opened at $68.09 on Wednesday. The stock has a market cap of $31.17 billion, a price-to-earnings ratio of 15.73, a PEG ratio of 3.19 and a beta of 1.14. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies has a 52 week low of $57.65 and a 52 week high of $94.80. The company’s 50 day moving average price is $75.62 and its 200-day moving average price is $81.81.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. On average, equities research analysts forecast that GE HealthCare Technologies will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.21%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.23%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Citigroup increased their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Piper Sandler dropped their price objective on GE HealthCare Technologies from $104.00 to $88.00 and set an “overweight” rating for the company in a report on Wednesday, April 23rd. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company upped their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Finally, BTIG Research set a $95.00 price objective on GE HealthCare Technologies and gave the stock a “buy” rating in a research note on Monday, April 14th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $96.50.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.